Navigation Links
New strategy developed to diagnose melanoma
Date:3/30/2009

A UCSF research team has developed a technique to distinguish benign moles from malignant melanomas by measuring differences in levels of genetic markers. Standard microscopic examinations of biopsied tissue can be ambiguous and somewhat subjective, the researchers say, and supplementing standard practice with the new technique is expected to help clarify difficult-to-diagnose cases.

In a large study of previously diagnosed cases, the new technique distinguished between benign, mole-like skin lesions and melanomas with a success rate higher than 90 percent. It also succeeded with most of the previously misdiagnosed cases, which were among the most difficult to distinguish.

This is the first large-scale study to demonstrate both the high diagnostic accuracy and practicality of a multi-biomarker approach to melanoma diagnosis, said Mohammed Kashani-Sabet, MD, professor of dermatology at UCSF and director of the Melanoma Center at the UCSF Helen Diller Family Comprehensive Cancer Center.

Kashani-Sabet is lead author on a paper reporting the new finding in the Proceedings of the National Academy of Sciences, which is scheduled for online publication the week of March 30, 2009. The paper also will appear in a future print issue of PNAS.

Melanoma is the deadliest form of skin cancer. It can spread to almost any organ of the body and is difficult to treat in its advanced stages. Progress in survival rates has been made principally through earlier diagnosis. The genomics-based approach combined with current diagnostic practice can aid earlier detection and contribute to more accurate assessment, report the UCSF scientists who developed the diagnostic tool.

The molecular diagnosis strategy is now being developed for clinical use by a diagnostics company.

To develop the diagnostic tool, the researchers first used a microarray a "gene chip" -- to identify about 1,000 human genes that were present at differ
'/>"/>

Contact: Susan Cohen
scohen@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. North Texas LEAD Offers Unique Approach to Job Search Strategy
2. Single embryo transfer is the cheapest and most effective strategy for assisted reproduction
3. Licorice compound offers new cancer prevention strategy
4. MRSA study suggests strategy shift needed to develop effective therapeutics
5. New strategy to weaken traumatic memories
6. New York State health IT strategy may be model for the nation
7. LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually
8. How to Increase Sales Margin 1 Percent to 10 Percent and Lower Your Risk by Building a Negotiation Strategy into Your Sales Process
9. LCA-Vision Reports Tangible Results from Business Strategy
10. New health reform strategy would insure everyone, improve health and slow spending growth
11. Health Care Workers Call on ARH Board Members to Meet, Develop Real Strategy to Deal With Hospitals Bottom Line

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Newswire/-SentinelleMedicalInc.,aleadingmanufactur...ndCalgaryScientificInc.,aleadingproviderofsoftware...gis(TM)Breast4DAdvancedVisualizationsoftware. ,...rintWebclientbasedmedicalimagingofferinginthemarke...ero-footprintaccess-requiringnosoftwaredownload,an...
(Date:11/25/2009)...e-USNewswire/--TheBlackAIDSInstituterecentlyheldBo...ipfor2010. ,, ThenewBoardMembersareahighlydiver...finance,governmenthealthprograms,editorial,andbusi...geofpersonalbackgroundsincludingbothheterosexualan...ndrepresentingmultipleagegroups. ,, (Photo: htt...
(Date:11/25/2009)...f a statistically significant survival benefit fro... receptor (ER)-positive tumors had high levels of ...ha S118-P), according to a brief communication pub...ational Cancer Institute . , Approximately 50% o...eclinical studies have shown that ER-alpha S118-P ...
(Date:11/25/2009)...eumatoid arthritis, could help newly diagnosed dia...25 (HealthDay News) -- A drug commonly used to tre... now also shows some promise in helping patients n..., rituximab (Rituxan), helped patients keep produc...ease had destroyed some of their pancreatic beta c...
(Date:11/25/2009)... signs of trouble with the H1N1 vaccine, , ...ngoing H1N1 swine flu pandemic may be driving a re...atients, a U.S. health official said Wednesday. ,...cal infections around the country," Dr. Anne Schuc...ion and Respiratory Diseases at the U.S. Centers f...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
...able in US GAAP, TORONTO, Jan. 29 /PRNewswire-Fir...g provider of products and services to the global ... issued its annual filings for,the first time unde... MD&A., To assist investors with understanding th...
... Cancer Treatment Expert,Starts 4-Year Term, CHIC...tary Michael Leavitt has appointed Timothy C. Bird... Advisory Council for Complementary,and Alternativ... a licensed naturopathic physician. A nationally,k...
...ological Disorders and Stroke has awarded $1.7 mil...gy researchers to study a condition that costs Ame...in is the leading cause of disability in Americans... more than three months and the cause can sometime...
...alth Plan,Inc., a leading provider of Medicare Adv...s enhanced its benefits for 2008 and further expan...ls of successful rollouts in,Oklahoma, Louisiana, ...n ever-expanding,provider and hospital network., ...
... with dense breasts benefit most, analysis confirm... For some women, digital mammography is a better b...confirms. , Women under the age 50 with dense brea...of radiology and biomedical engineering at the Uni...
...a,medical worry, but serious cases can result in c...mmation. This is one problem that hasn,t suffered,... there are dozens of,creams and lotions for dry sk...s of obscure ingredients and the,pseudoscientific ...
Other Medicine News:Health News:National Institutes of Health Appoints Timothy C. Birdsall, ND to CAM Advisory Council 2Health News:UC scientists awarded $1.7 million for low back pain research 2Health News:A Bright Future for Medicare Beneficiaries in Maine 2Health News:Digital Mammography Better Than Film for Some Women 2Health News:Digital Mammography Better Than Film for Some Women 3Health News:Tips for Dry Winter Skin, From the Harvard Health Letter 2
(Date:11/24/2009)...wire-FirstCall/--Vermillion,Inc.(VRML)(PinkSheets:...ionandDisclosureStatementtoday,November24,2009,wit...aware.AhearingtoconsiderapprovaloftheDisclosureSta...ehearingontheconfirmationofthePlanscheduledforJanu...claimsinfull.ThePlanisexpected,ifapproved,toallowh...
(Date:11/24/2009)...,Nov.24/PRNewswire/-- EisaiInc.andPfizerIncannoun...asacceptedforreviewEisai,sNewDrugApplication(NDA)f...elease)tabletsforthetreatmentofmoderatetosevereAlz...ntains23mgofdonepezilHClinanextendedrelease,matrix...releaseofthedrug.TheNDAisbasedonahead-to-headclini...
(Date:11/24/2009)...ewswire-FirstCall/--ThoratecCorporation(Nasdaq: TH...rysupporttherapiestosave,supportandrestorefailingh...nnualPiperJaffrayHealthCareConferenceonTuesday,Dec...ndchieffinancialofficer,willprovideanupdateontheco...a.m.,PacificStandardTime). ,, Thepresentationwi...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3I Therapeutix Inc Announces Company Name Change 58217 1President Clinton Hosts Special Session on Northern Ireland 3B Announces New Commitments Focused on Harnessing Innovation for Development 58215 1President Clinton Hosts Special Session on Northern Ireland 3B Announces New Commitments Focused on Harnessing Innovation for Development 58215 2President Clinton Hosts Special Session on Northern Ireland 3B Announces New Commitments Focused on Harnessing Innovation for Development 58215 3President Clinton Hosts Special Session on Northern Ireland 3B Announces New Commitments Focused on Harnessing Innovation for Development 58215 4President Clinton Hosts Special Session on Northern Ireland 3B Announces New Commitments Focused on Harnessing Innovation for Development 58215 5President Clinton Hosts Special Session on Northern Ireland 3B Announces New Commitments Focused on Harnessing Innovation for Development 58215 6President Clinton Hosts Special Session on Northern Ireland 3B Announces New Commitments Focused on Harnessing Innovation for Development 58215 7President Clinton Hosts Special Session on Northern Ireland 3B Announces New Commitments Focused on Harnessing Innovation for Development 58215 8President Clinton Hosts Special Session on Northern Ireland 3B Announces New Commitments Focused on Harnessing Innovation for Development 58215 9OneDotOneLife org Saving the Lives of More Than 2 Million Children 5048 1OneDotOneLife org Saving the Lives of More Than 2 Million Children 5048 2
...Cougar Biotechnology,Inc. (OTCBB: CGRB) today ann...data on the Company,s prostate cancer drug candida...he American Society,of Clinical Oncology (ASCO) An...hicago, Illinois. The data was presented in two,po...of the poster,discussion session for genitourinary...
...re-FirstCall/ --,Bionovo, Inc.,s lead drug candida... treatment of hot flashes associated with menopaus...n the company,s,double-blind, placebo- controlled,...th 50 or more moderate to severe hot flashes,per w...ps receiving,MF101 (5 grams/day), MF101 (10 grams/...
Other Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 4Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 5Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at ASCO Annual Meeting 6Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 2Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 3Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 4Bionovo's MF101 Shows Positive Safety, Tolerability and Efficacy in,Phase 2 Trial 5
Ballard Neonatal and Pediatric Trach Care Manifold
...elit® PVC siliconized. Stainless steel spiral ...e/high volume cuff. Adjustable neck band. Single u...along the tube shaft to suit the thickness of the ...kwise until the flange is tightly connected to the...
Soft PVC Tracheostomy Tubes
...x® Blue Line ULTRA® Suctionaid® trache... effective removal of secretions from above the tr...TRA® Suctionaid® tracheostomy tubes provid...of secretions from above the tracheostomy tube cuf...
Medicine Products: